- Case report
- Open Access
Locally advanced duodenal gangliocytic paraganglioma treated with adjuvant radiation therapy: case report and review of the literature
© Wong et al; licensee BioMed Central Ltd. 2005
- Received: 17 December 2004
- Accepted: 01 March 2005
- Published: 01 March 2005
Gangliocytic paraganglioma are rare neoplasms that predominantly arise in periampulary region. Though considered benign the disease can spread to regional lymphatics.
A 49 year old woman presented with melena and was found to have a periampullary mass. Endoscopic evaluation and biopsy demonstrated a periampullary paraganglioma. The tumor was resected with pylorus-preserving pancreaticoduodenectomy and was found to represent a gangliocytic paraganglioma associated with nodal metastases. In a controversial decision, the patient was treated with adjuvant external beam radiation therapy. She is alive and well one year following resection. The authors have reviewed the current literature pertaining to this entity and have discussed the biologic behavior of the tumor as well as the rationale for treatment strategies employed.
Paraganglioma is a rare tumor that typically resides in the gastrointestinal tract and demonstrates low malignant potential. Due to rarity of the disease there is no consensus on the adjuvant treatment even though nearly 5% of the lesions demonstrate the malignant potential.
- Pancreatic Polypeptide
- Regional Lymph Node Metastasis
- Islet Cell Tumor
- Gangliocytic Paraganglioma
Gangliocytic paragangliomas are unusual neoplasms that may be identified anywhere within the gastrointestinal tract, but predominate in the periampullary region. This entity was first discussed by Dahl et al in 1957, and subsequently reported by Taylor and Helwig in 1962 [1, 2]. Kepes and Zacharias named the tumor and described its characteristics in 1971 . The pathognomonic features of these neoplasm is the identification of three distinct cellular elements: spindle cells, epithelial cells, and ganglion cells. These tumors are considered benign, yet occasionally metastasize to regional lymph nodes, as well as to distant organs . Long term survival is common with appropriate resection. We report a case of a 49-year-old female who presented with melena and was found to have a periampullary gangliocytic duodenal paraganglioma. The details of the clinical presentation, histopathological findings, and therapeutic choices are provided.
The patient underwent pylorus-preserving pancreaticoduodenectomy and lymph node dissection. The postoperative course was uneventful except for delayed gastric emptying diagnosed by frequent vomiting during postoperative days 7 to 10, and confirmed by gastrograffin swallow. These symptoms eventually resolved with conservative management and the patient was discharged from the hospital on 15th postoperative day.
Gross pathological evaluation of the resected specimen included a portion of duodenum with ampulla, measuring 16 cm. in length, and a portion of pancreatic head measuring 5 cm. in length. There was a polypoid periampullary mass protruding into the duodenal lumen, measuring 1.4 × 1.2 × 0.7 cm. On cut section, the mass was moderately firm and pink-tan. It was circumscribed but unencapsulated, and appeared to be covered by normal appearing duodenal mucosa. There was no evidence of pancreatic invasion by the tumor. A total of seven lymph nodes were also removed, 5 peripancreatic (3.0 cm in greatest dimension) and 2 periduodenal (1.2 cm and 1.0 cm in greatest dimension, respectively).
Immunohistochemical analysis demonstrated that the tumor stained positively for S-100, chromogranin, synaptophysin, and cytokeratin AE1 and AE3. No reactivity was observed with MART-1 or HMB 45. Staining for c-kit (CD 117) was performed on sections of the primary tumor and of one of the lymph nodes with metastatic tumor. The carcinoid-like epithelial cells and the spindle-shaped neurofibrillar cells stained negatively for the cell marker c-Kit. The gangliocytic cells stained strongly positive for c-kit.
Due to the evidence of regional lymph node metastasis the patient was counseled regarding adjuvant therapeutic options. The treating physicians queried recognized experts in the field of radiation therapy for gastrointestinal malignancies via email and a consensus developed that external beam radiation therapy might be reasonable, although it was admitted that no data are available regarding the use of this modality for this disease entity. Ultimately, a decision was made to administer external beam radiotherapy to the abdomen in an effort to eradicate any possible residual disease not removed during surgery and to reduce the risk of locally recurrent disease. No chemotherapy was advised due to the rarity of distant metastases and the lack of response of these neoplasms to conventional systemic therapy.
The patient was treated with intensity-modulated radiotherapy in 28 fractions of 180 cGy/fraction over 37 elapsed days; 6 mv photon beam energy was used. The target was a postoperative tumor bed with a 5–10 mm margin. The total dose was 5,040 cGy. She tolerated treatment well and is now symptom free more than one year following resection. Surveillance CT scans and endoscopy have been performed both of which reveal no evidence of recurrent disease.
Gangliocytic paraganglioma is a rare, typically benign tumor of the gastrointestinal tract most commonly located in the second portion of the duodenum, with a few cases having involved the jejunum and pylorus [5–7]. Burke et al reported that there seems to be a slight male predominance and an average age of 54 at presentation . Other authors have denied that there is any gender preference . This lesion usually presents with abdominal pain and gastrointestinal bleeding due to mucosal ulceration. Obstructive jaundice is less common .
Histologically, our patient's tumor demonstrated the characteristic tricellular pattern of gangliocytic paragangliomas. These tumors are typically composed of an admixture of ganglion cells, spindle cells and epithelial cells [5, 10–13]. These tumors are submucosal, and rarely recur or metastasize [14–16]. In most reported cases regional lymph node involvement, the metastatic cells consist predominantly of epithelial cells . A relatively unique element of the case we present is that six of 7 regional lymph node metastases contained all three characteristic cell types, and thus, demonstrated the possibility for each of these cell types to acquire a malignant potential.
Immunohistochemically these tumors stain positive for a variety of markers as was demonstrated in this report. Such markers include those mentioned above as well as neuron-specific enolase, pancreatic polypeptide, somatostatin, myelin basic protein and neurofilament proteins [6, 12, 13, 17]. The origin of gangliocytic paragangliomas has been widely debated and includes hypotheses ranging from a hamartomatous derivation to cellular elements arising from pancreatic neuroendocrine tissue, or that of the retroperitoneal celiac sympathetic or parasympathetic plexuses [4, 12].
There is no data in the literature to guide clinicians on the use of adjuvant therapy despite the fact that approximately 5% of cases demonstrate malignant features . Since this patient had multiple positive lymph nodes and is relatively young, a trial of adjuvant radiotherapy to the operative bed was considered reasonable and was endorsed by radiation oncologists at high volume cancer centers queried via email.
Gangliocytic paraganglioma is a rare duodenal tumor that can present with non-specific symptoms. Positive diagnosis can be obtained histologically by observing three characteristic cell types. Although this tumor is considered benign, the possibility exists for regional lymph nodal spread. Due to the rarity of the disease, no clear adjuvant treatment strategy has been determined in cases that demonstrate regional or distant metastasis.
Written consent was obtained from the patient for publication of this study and the related photos.
- Dahl EV, Waugh JM, Dahlin DC: Gastrointestinal ganglioneuromas: brief review with report of a duodenal ganglioneuroma. Am J Pathol. 1957, 33: 953-966.PubMed CentralPubMedGoogle Scholar
- Taylor HB, Helwig EB: Benign nonchromaffin paragangliomas of the duodenum. Virchows Arch Pathol Anat Physiol Klin Med. 1962, 335: 356-366. 10.1007/BF00957029.View ArticlePubMedGoogle Scholar
- Kepes JJ, Zacharias DL: Gangliocytic paragangliomas of the duodenum: a report of two cases with light and electron microscopic examination. Cancer. 1971, 27: 61-70.View ArticlePubMedGoogle Scholar
- Bucher P, Mathe Z, Buhler L, Chilcott M, Gervaz P, Egger J-F, Morel Ph: Paraganglioma of the ampulla of Vater: a potentially malignant neoplasm. Scand J Gastroenterol. 2004, 3: 291-295.View ArticleGoogle Scholar
- Sundararajan V, Robinson-Smith TM, Lowy AM: Duodenal gangliocytic paraganglioma with lymph node metastasis: a case report and review of the literature. Arch Pathol Lab Med. 2003, 127: e139-e141.PubMedGoogle Scholar
- Burke AP, Helwig EB: Gangliocytic paraganglioma. Am J Clin Pathol. 1989, 92: 1-9.PubMedGoogle Scholar
- Reed RJ, Caroca PJ, Harkin JC: Gangliocytic paraganglioma. Am J Surg Pathol. 1977, 1: 207-216.View ArticlePubMedGoogle Scholar
- Scheithauer BW, Nora FE, LeChago J, Wick MR, Crawford BG, Weiland LH, Carney JA: Duodenal gangliocytic paraganglioma. Clinicopathologic and immunocytochemical study of 11 cases. Am J Clin Pathol. 1986, 86: 559-565.PubMedGoogle Scholar
- Evans JD, Wilson PG, Barber PC, Neoptolemos JP: Duodenal gangliocytic paraganglioma presenting as an ampullary tumor. Int J Pancreatol. 1996, 20: 131-134.PubMedGoogle Scholar
- Girgis PA, Henthorne WA: Pathologic quiz case. Mass at the ampulla of vater in a 43-year-old man. Gangliocytic paraganglioma. Arch Pathol Lab Med. 2002, 126: 1239-1240.PubMedGoogle Scholar
- Perrone T, Sibley RK, Rosai J: Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol. 1985, 9: 31-41.View ArticlePubMedGoogle Scholar
- Sakhuja P, Malhotra V, Gondal R, Dutt N, Choudhary A: Periampullary gangliocytic paraganglioma. J Clin Gastroenterol. 2001, 33: 154-156. 10.1097/00004836-200108000-00013.View ArticlePubMedGoogle Scholar
- Barbareschi M, Frigo B, Aldovini D, Leonardi E, Cristina S, Falleni M: Duodenal gangliocytic paraganglioma. Report of a case and review of the literature. Virchows Arch A Pathol Anat Histopathol. 1989, 416: 81-89.View ArticlePubMedGoogle Scholar
- Inai K, Kobuke T, Yonehara S, Tokuoka S: Duodenal gangliocytic paraganglioma with lymph node metastasis in a 17-year-old boy. Cancer. 1989, 63: 2540-2545.View ArticlePubMedGoogle Scholar
- Hashimoto S, Kawasaki S, Matsuzawa K, Harada H, Makuuchi M: Gangliocytic paraganglioma of the papilla of Vater with regional lymph node metastasis. Am J Gastroenterol. 1992, 87: 1216-1218.PubMedGoogle Scholar
- Dookhan DB, Miettinen M, Finkel G, Gibas Z: Recurrent duodenal gangliocytic paraganglioma with lymph node metastases. Histopathology. 1993, 22: 399-401.View ArticlePubMedGoogle Scholar
- Furihata M, Sonobe H, Iwata J, Ido E, Ohtsuki Y, Ohnishi S: Immunohistochemical characterization of a case of duodenal gangliocytic paraganglioma. Pathol Int. 1996, 46: 610-613.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.